English | Español

Biospace
Patient Daily | Feb 6, 2026

Lilly reports strong Q4 results as Mounjaro and Zepbound drive revenue growth
Patient Daily | Feb 6, 2026

Pfizer releases early Metsera obesity drug data; FDA decisions expected on key therapies
Patient Daily | Feb 6, 2026

Amgen highlights extended dosing potential for obesity drug MariTide
Patient Daily | Feb 6, 2026

Amgen declines FDA request to withdraw rare disease drug Tavneos
Patient Daily | Feb 6, 2026

Novartis maintains acquisition focus while reporting strong financial results
Patient Daily | Feb 6, 2026

GSK focuses on complications from obesity rather than GLP-1 drugs
Patient Daily | Feb 6, 2026

Eli Lilly sees opportunity as Novo Nordisk's oral Wegovy expands obesity drug market
Patient Daily | Feb 6, 2026

Congressman questions transparency of FDA's priority voucher program

Trending
+ Pharmaceuticals
Patient Daily | Mar 9, 2026

Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
+ Regulatory
Patient Daily | Mar 9, 2026

Pharmacy owner Kiefer on PBMs: 'Independent pharmacies are being aggressively pushed out of business by the monopolistic practices of PBMs'
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Alnylam partners with Tenaya Therapeutics on genetic heart disease research
+ Pharmaceuticals
Patient Daily | Mar 11, 2026

Salk scientists find key protein linking GLP-1 drug benefits to pancreatic cell health